Better Coronavirus Stock: Inovio Pharmaceuticals or Regeneron?
One welcome sign with the COVID-19 pandemic is how many companies, both large and small, have scrambled to develop diagnostic tests, antiviral treatments, and vaccines. Sure, these companies are in business to make money and have a profit motive behind their efforts. But every company has the same motivation. For that matter, nearly every person is motivated by making money.
Inovio Pharmaceuticals (NASDAQ: INO) ranks as one of the leaders in the race to develop a COVID-19 vaccine. Regeneron Pharmaceuticals (NASDAQ: REGN) is among the top contenders in developing an antiviral treatment for the novel coronavirus disease. Which of these two coronavirus-focused biotech stocks is the better pick for investors who have their own profit motivation?
Image source: Getty Images.
Source Fool.com
